Adult Diffuse Midline Glioma, H3 K27-Mutant
general17
Centers
17
Active Trials
$5.7B
Cancer Funding
Specific Cancer Types(1)
Top Centers for Adult Diffuse Midline Glioma, H3 K27-Mutant(17)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive | — |
| 2 | Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive | — |
| 3 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive | — |
| 4 | Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive | — |
| 5 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive | — |
| 6 | NCI Comprehensive | — |
| 7 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive | — |
| 8 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive | — |
| 9 | NCI Comprehensive | — |
| 10 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive | — |
| 11 | UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive | — |
| 12 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive | — |
| 13 | NCI Clinical | — |
| 14 | NCI Comprehensive | — |
| 15 | VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive | — |
| 16 | University of Illinois Cancer CenterChicago, IL | — |
| 17 | Cancer Center at IllinoisUrbana, IL | — |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →